PF-Atlas › Clinical Trials › NCT06053164
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
Exertional Oxygen · Phase 2
Registry ID
NCT06053164
Phase
Phase 2
Status
Recruiting
Drug / intervention
Exertional Oxygen
Sponsor
University of Alberta
Start
2025-07-01
Enrollment
60
Locations
1
About this trial
The investigators plan to conduct a study to find out if giving portable oxygen therapy (during physical activity) to patients with interstitial lung disease will improve quality of life, exercise tolerance, shortness of breath, and blood vessel function. Oxygen will be provided for a period of 8 weeks. Additionally, the investigators plan to investigate if it is helpful to deliver individualized support when providing oxygen therapy, through check-in phone calls with a respiratory therapist and by providing additional educational material.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06053164 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.